Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Cardiome Pharma Corp    COM   CA14159U3010

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Engages in the discovery, development and commercialization of new therapies

Cardiome Pharma Corp. is a pharmaceutical company engages in provision of development and commercialization of medical products.

It focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease.

It offers the Brinavess and Aggrastat products to customers such as physicians, patients, and healthcare systems.

The company was founded on December 12, 1986 and is headquartered in Vancouver, Canada.



Number of employees : 85 persons.
Sales per Businesses
20142015Delta
CAD (in Million)%CAD (in Million)%
Cardiovascular Therapies33.18100%26.75100% -19.37%
Sales per Regions
20142015Delta
CAD (in Million)%CAD (in Million)%
Rest of World17.3852.4%13.2349.4% -23.89%
Europe15.8047.6%13.5350.6% -14.41%
Managers
NameAgeSinceTitle
William L. Hunter, MD532007President, Chief Executive Officer & Director
William James O'Shea672014Chairman
Sheila M. Grant, MBA-2003Chief Operating Officer
Jennifer Archibald-2006Chief Financial Officer
Richard M. Glickman, PhD592006Lead Independent Director
Mark H. N. Corrigan, MD592015Director
Arthur H. Willms772015Independent Director
Robert James Meyer, MD-2015Director
Hugues Sachot-2013Senior Vice President-Sales & Commercial
Steen Juul-Möller MD, PhD-2013Medical Director-Europe
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 31,884,420 31,277,363 98.1% 0 0.0% 98.1%
Shareholders
NameEquities%
Westfield Capital Management Co. LP 5,078,393 15.9%
Putnam Investment Management LLC 3,683,481 11.6%
Tamarack Advisers LP 2,200,000 6.90%
Clough Capital Partners LP 2,044,653 6.41%
Stonepine Capital Management LLC 1,778,317 5.58%
Rock Springs Capital Management LP 1,200,000 3.76%
William L. Hunter, MD 607,452 1.91%
AlphaOne Investment Services LLC 550,965 1.73%
Sabby Capital LLC 437,720 1.37%
Renaissance Technologies LLC 215,013 0.67%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Advertisement
Sector Biopharmaceuticals
1st jan.Capitalization (M$)
CARDIOME PHARMA CORP-1.26%95
BIOGEN INC9.78%61 957
CSL LIMITED19.31%41 752
ALEXION PHARMACEUTICAL..6.16%29 175
BIOMARIN PHARMACEUTICA..8.93%15 520
GRIFOLS SA11.89%14 042
3SBIO INC0.39%2 488
JIANGXI BOYA BIO-PHARM..--.--%2 209
ABCAM PLC13.04%2 205
PROMETIC LIFE SCIENCES..9.65%1 186
HUGEL INC--.--%1 092
BIOTEST AG16.07%755
ANIKA THERAPEUTICS INC0.49%719
PHARMA MAR SA12.36%712
ARGOS THERAPEUTICS INC-10.20%181
MEDIWOUND LTD34.30%135
VIVUS, INC.-4.35%115
VERICEL CORP1.67%97
ALIMERA SCIENCES INC15.74%81
CO DON AG41.46%72
STEADYMED LTD23.08%63
Sector Biopharmaceuticals
Cardiome Pharma Corp : Connections
Zalicus Pharmaceuticals Ltd.
Richardson Capital Ltd.
Kyowa Kirin International Plc
Trevi Therapeutics, Inc.
Premier's Technology Council
Pacific Autism Family Centre Foundation
Brighton Biotech, Inc.
Blackthorn Therapeutics, Inc.
Quartet Medicine, Inc.
Synereca Pharmaceuticals, Inc.
Michael Smith Foundation for Health Research
British Columbia Lottery Corp.
Pamlico BioPharma, Inc.
The 2010 Games Operating Trust
Vancouver Symphony Orchestra
enGene, Inc.
MedGenesis Therapeutix, Inc.
The Vancouver Symphony Foundation
Vida Pharmaceuticals Pvt Ltd.
Advanced Applied Physics Solutions, Inc.
Kearny Venture Partners
Virginia Center For Translational & Regulatory Sciences
Company contact information
Cardiome Pharma Corp.
1441 Creekside Drive
6th Floor
Vancouver, BC V6J 4S7

Phone : +1.604.677.6905
Fax : +1.604.677.6915
Web : www.cardiome.com
© 2017 People , Fundamentals and Ownership